Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
abacavir (ziagen) (1 trial)
atazanavir (reyataz) (1 trial)
darunavir (prezista) (1 trial)
dolutegravir (tivicay) (1 trial)
echinacea (1 trial)
fosamprenavir (lexiva) (1 trial)
lamivudine (epivir) (1 trial)
lopinavir (Kaletra) (1 trial)
ritonavir (Norvir) (1 trial)
silymarin (1 trial)
raltegravir (isentress) (1 trial)
3bnc117 (1 trial)
alprostadil (prostin) (1 trial)
blood plasma (1 trial)
COVID-19 convalescent plasma (1 trial)
dasatinib (sprycel) (1 trial)
ihivarna (1 trial)
papaverine (1 trial)
phentolamine mesylate (regitine) (1 trial)
trimix (1 trial)
chadox1.hti (1 trial)
chadv63.hivconsv (1 trial)
mva.hivconsv (2 trials)
romidepsin (istodax) (1 trial)
sodium chloride (1 trial)
cetylpyridinium chloride (1 trial)
HIV Infections (Phase 4)
Infections (Phase 2)
Trials (13 total)
Trial APIs (26 total)